Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index; 11 of the 60 sources its claims cite were checked for support.

Zoological transmission of encephalomyocarditis virus in the United States: Virus evolution, host ecology, and capsid antigenicity derived from an outbreak

Open access

Abstract

Encephalomyocarditis virus (EMCV) is a rodent-borne picornavirus that has repeatedly caused severe outbreaks resulting in the deaths of zoo mammals – most notably elephants – for decades. However, within North America, little is known regarding the diversity of EMCV that exists in nature, the reservoir or amplifying hosts important for maintaining the virus, and the epidemiology of zoo-associated outbreaks. This lack of knowledge of the EMCV strains that circulate in North America has impeded a more thorough understanding of how genetic and antigenic variation may affect pathogenicity or potentially vaccine-induced protection from disease. Herein, following a zoological outbreak of EMCV in Florida, we conducted the most comprehensive comparative phylogenomic analysis of virus isolates from fatal zoo animal cases and local rodent species to date, identifying both non-native, invasive rodents and native mice and rat species as potentially important in precipitating and/or maintaining outbreaks, with multiple transmissions to zoo animals. After development of an autogenous vaccine, we investigated the duration and magnitude of neutralizing antibody responses in elephants monthly for multiple years, providing a unique fine-scale, long-term profile of responses to vaccination. To better understand how antigenic variation may affect vaccine-induced protection, we constructed a reverse genetics system to determine the level of cross-protection afforded by autogenous vaccination against capsids derived from various divergent EMCV strains and serotypes. These results provide new advancements in understanding EMCV transmission and antigenicity in North America, which can be used as a foundation to ultimately enable zoos to better protect animals from this important pathogen.

Overview

CoChat Summary

TL;DR

Following a 2019 EMCV outbreak at a central Florida zoo that killed an African elephant, three mandrills, a North Sulawesi babirusa, and a lion-tailed macaque, the authors combined phylogenomics of zoo and rodent isolates, long-term serology after autogenous vaccination, and reverse genetics to examine transmission, evolution, and capsid antigenicity. They found multiple rodent-to-zoo transmissions involving invasive black rats and native rodents, slow waning of vaccine-induced neutralizing antibodies in elephants, and cross-neutralization of divergent EMCV-1 variants but not EMCV-2.

Key findings

  • The outbreak spanned 26 days and caused six zoo animal deaths; EMCV was isolated from all heart samples (Ct 15.0–21.8). Among 347 rodents collected during the outbreak, 246 were tested by qRT-PCR, 85 were positive (34.6%), and virus was recovered from 9 of 24 qRT-PCR-positive samples tested (37.5%), including 7 black rats, 1 eastern woodrat, and 1 cotton mouse.
  • Complete/near-complete genomes of 21 outbreak and post-outbreak EMCV isolates from zoo animals and rodents shared 98.3–99.9% nucleotide identity; rodent and zoo animal viruses intermixed phylogenetically, indicating multiple rodent-to-zoo transmissions and cross-species transmission between invasive black rats and native rodents. The closest relative was EMCV-30 from Minnesota swine in 1987.
  • In nine vaccinated African elephants monitored approximately monthly for 2.5 years, all had detectable mean antibody titers ≥1:49, 7 of 9 did not require a booster, and neutralizing antibodies waned slowly (slope = -0.014 [95% CI: -0.018 to -0.010], R² = 0.62, P < 0.0001). Rhino titers also waned slowly (slope = -0.025 [95% CI: -0.032 to -0.017], R² = 0.63, P < 0.0001), with white rhino SWR-05 reaching a mean titer of 1:3,151 and SWR-04 a mean of 1:911.
  • Reverse-genetics chimeric capsids showed neutralization titers of 1:640 against homologous N-037–19, 1:160 against EMCV-1 ZM12/14 (39 capsid substitutions), 1:80 against putative EMCV-3 Sing-M100-02 (74 substitutions), and 0 against EMCV-2 RD-1338 (200 substitutions). Complete neutralization of Sing-M100-02 by EMCV-1 antisera suggested it is a divergent EMCV-1 variant rather than a novel serotype.

Methods

  • Outbreak investigation: clinical and pathological examination of six fatal zoo cases; virus isolation from heart and pooled tissues in Vero E6 and BHK-21 cells; rodent trapping with qRT-PCR and virus isolation; cytochrome B PCR and Sanger sequencing for rodent species identification.
  • Genomics and phylogenetics: RNA-Seq and de novo assembly of complete/near-complete EMCV genomes from 21 outbreak/post-outbreak isolates plus two comparison viruses; maximum likelihood phylogenies for full genome, polyprotein, capsid, and 3D sequences using MAFFT/Muscle, Gblocks, and PhyML; capsid substitutions mapped onto the Mengo virus capsid structure (PDB 2mev).
  • Vaccination, serology, and reverse genetics: autogenous inactivated vaccines administered to elephants and rhinos; monthly PRNT90 testing with linear regression and ANOVA; construction of an infectious clone for N-037–19 using pcDNA3.1 with hammerhead and HDV ribozymes and a 30-nt poly-A tail; chimeric capsid viruses rescued in Vero E6 cells and assessed by immunofluorescence and multi-step growth curves.

Limitations

  • Stated: 5′ RACE was unsuccessful and some genomes were missing 2–14 nt at the 5′ end; polyC tract lengths from cDNA/RNA-Seq are inaccurate due to homopolymer sequencing limitations; direct RNA sequencing was only successful for the prototype elephant virus; archived tissues from other zoo animals yielded insufficient high-quality polyadenylated RNA. The authors also state that without growth curves for the corresponding wild-type viruses, it is impossible to know whether the lower fitness of chimeric viruses is due to their chimeric configuration, and that accurate tracking of transmission directionality during outbreaks is challenging.
  • Stated: animal challenge experiments in elephants and rhinos were not feasible, so vaccine protection is inferred from neutralizing antibody titers; serotype designations for EMCV-3, EMCV-4, and EMCV-5 remain based on genetic/phylogenetic divergence without comprehensive serological testing.
  • Evident from the text: the study is based on a single outbreak at one zoo, with small numbers of vaccinated elephants (nine) and rhinos, no unvaccinated control animals, and observational serology rather than experimental challenge, which limits causal inference about vaccine efficacy and transmission dynamics.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1013861

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 Clinical syndromes and associated gross and microscopic cardiac lesions noted in primate and non-primate zoo animals infected with EMCV during the outbreak. (A) Mandrill #3 heart: Clinical presentation of EMCV infection in primates – three mandrills and a lion-tailed macaque – was associated with intractable and progressive lethargy and dyspnea, decreased ventricular contractility, and signs consistent with congestive heart failure leading to death or euthanasia. Lesions at necropsy included pericardial, thoracic, and abdominal effusion, along with pulmonary edema. Note the pale streak-like areas on the heart (myocardial pallor) without epicardial or myocardial hemorrhages; (B) North Sulawesi babirusa heart: In contrast to the primate cases, gross lesions in the babirusa and African elephant centered on the heart and were characterized by broad, confluent areas of acute hemorrhage throughout the epicardium. Hemorrhages extended into the myocardium, interspersed with areas of myocardial pallor. Clinical presentation in both cases – babirusa and elephant – was sudden death with no, or limited and vague, premonitory signs; (C) Mandrill #3 heart: Patchy areas of myofiber degeneration and necrosis, with edema and mild to moderate neutrophilic and lymphocytic inflammation (20x magnification; hematoxylin and eosin [H&E] stain); (D) North Sulawesi babirusa heart: Hemorrhage along the epicardial surface and myocardium with myonecrosis, edema, and moderate neutrophilic and lymphocytic inflammation (10x magnification; H&E stain).
Fig 1 Clinical syndromes and associated gross and microscopic cardiac lesions noted in primate and non-primate zoo animals infected with EMCV during the outbreak. (A) Mandrill #3 heart: Clinical presentation of EMCV infection in primates – three mandrills and a lion-tailed macaque – was associated with intractable and progressive lethargy and dyspnea, decreased ventricular contractility, and signs consistent with congestive heart failure leading to death or euthanasia. Lesions at necropsy included pericardial, thoracic, and abdominal effusion, along with pulmonary edema. Note the pale streak-like areas on the heart (myocardial pallor) without epicardial or myocardial hemorrhages; (B) North Sulawesi babirusa heart: In contrast to the primate cases, gross lesions in the babirusa and African elephant centered on the heart and were characterized by broad, confluent areas of acute hemorrhage throughout the epicardium. Hemorrhages extended into the myocardium, interspersed with areas of myocardial pallor. Clinical presentation in both cases – babirusa and elephant – was sudden death with no, or limited and vague, premonitory signs; (C) Mandrill #3 heart: Patchy areas of myofiber degeneration and necrosis, with edema and mild to moderate neutrophilic and lymphocytic inflammation (20x magnification; hematoxylin and eosin [H&E] stain); (D) North Sulawesi babirusa heart: Hemorrhage along the epicardial surface and myocardium with myonecrosis, edema, and moderate neutrophilic and lymphocytic inflammation (10x magnification; H&E stain).CC BY · PubMed Central
Fig 2 Evolutionary analysis of a zoological outbreak of EMCV using complete genomes from zoo animals and rodents. (A) A maximum likelihood phylogeny is shown based on complete genome nucleotide sequences of the 21 viruses isolated during the central Florida outbreak, along with a worldwide collection of EMCVs from Asia, Europe, Africa, and North America. For the 21 outbreak viruses, those recovered from zoo animals, invasive non-native rodents, and native rodents are shown in blue, black and green, respectively. The tree is mid-point rooted for clarity only. Horizontal branch lengths are scaled according to the number of nucleotide substitutions per site as shown, along with SH-like branch supports >0.9. Viruses are labeled as: species scientific name/ virus ID/ GenBank accession number/ state (where applicable)/ country/ detection or isolation date; (B) Summary of the 15 EMCV isolates recovered from zoo animals and rodents during the outbreak (27 March 2019 – 22 April 2019), in addition to 6 viruses isolated during post-outbreak rodent surveillance (27 July 2019 – 23 February 2021). Recovery of viruses is shown in chronological order by date of animal death (i.e., fatal zoo animal infection or rodent trapping). Virus isolate ID and source of tissue used for isolation and genomic sequencing are shown, with the concomitant NCBI accession numbers for each genome; (C) Maximum likelihood phylogeny of the complete genome nucleotide sequences of the 21 outbreak viruses in isolation. The tree is mid-point rooted for clarity only. Horizontal branch lengths are scaled according to the number of nucleotide substitutions per site as shown, along with SH-like branch supports >0.9. Viruses are labeled as: host common name/ virus ID/ isolation date and are color-coded as in panel A and B. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/y37pu4t). Additional images were obtained from VectorStock [95].
Fig 2 Evolutionary analysis of a zoological outbreak of EMCV using complete genomes from zoo animals and rodents. (A) A maximum likelihood phylogeny is shown based on complete genome nucleotide sequences of the 21 viruses isolated during the central Florida outbreak, along with a worldwide collection of EMCVs from Asia, Europe, Africa, and North America. For the 21 outbreak viruses, those recovered from zoo animals, invasive non-native rodents, and native rodents are shown in blue, black and green, respectively. The tree is mid-point rooted for clarity only. Horizontal branch lengths are scaled according to the number of nucleotide substitutions per site as shown, along with SH-like branch supports >0.9. Viruses are labeled as: species scientific name/ virus ID/ GenBank accession number/ state (where applicable)/ country/ detection or isolation date; (B) Summary of the 15 EMCV isolates recovered from zoo animals and rodents during the outbreak (27 March 2019 – 22 April 2019), in addition to 6 viruses isolated during post-outbreak rodent surveillance (27 July 2019 – 23 February 2021). Recovery of viruses is shown in chronological order by date of animal death (i.e., fatal zoo animal infection or rodent trapping). Virus isolate ID and source of tissue used for isolation and genomic sequencing are shown, with the concomitant NCBI accession numbers for each genome; (C) Maximum likelihood phylogeny of the complete genome nucleotide sequences of the 21 outbreak viruses in isolation. The tree is mid-point rooted for clarity only. Horizontal branch lengths are scaled according to the number of nucleotide substitutions per site as shown, along with SH-like branch supports >0.9. Viruses are labeled as: host common name/ virus ID/ isolation date and are color-coded as in panel A and B. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/y37pu4t). Additional images were obtained from VectorStock [95].CC BY · PubMed Central
Fig 3 Maximum likelihood amino acid phylogeny based on capsid (VP4-VP2-VP3-VP1) sequences of EMCV. The capsid amino acid phylogeny was inferred using sequences of the 21 viruses isolated during the central Florida outbreak, along with EMCVs from Asia, Europe, Africa, and North America. In addition to the prototype outbreak elephant isolate (N-037-19), five other viruses analyzed in subsequent experiments (Figs 7 and 8) are highlighted in the tree: (i) EMCV N-20-413, isolated from a common brown lemur from a zoological facility in south Florida in 2020 (serotype 1), (ii) EMCV N-19-013, derived from an East African hippopotamus at a Texas zoo in 2018 (serotype 1), (iii) EMCV ZM12/14, isolated from a multimammate mouse in Zambia in 2012 (serotype 1), (iv) EMCV RD-1338, recovered from a wood mouse in Germany in 2005 (serotype 2), and (v) EMCV Sing-M100-02, isolated from an orangutan in Singapore in 2002 (tentatively designated as serotype 3). Nonsynonymous amino acid changes in the five viruses relative to N-037-19 were mapped onto the Mengo virus capsid crystal structure (pdb_00002mev) using PyMOL and are highlighted in red. The tree is mid-point rooted for clarity only. Horizontal branch lengths are scaled according to the number of amino acid substitutions per site. Only SH-like branch supports >0.9 are shown. Viruses are labeled as: host scientific name/ virus ID/ GenBank accession number/ state (where applicable)/ country/ detection or isolation date. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/ej9nobp). Additional images were obtained from VectorStock [95].
Fig 3 Maximum likelihood amino acid phylogeny based on capsid (VP4-VP2-VP3-VP1) sequences of EMCV. The capsid amino acid phylogeny was inferred using sequences of the 21 viruses isolated during the central Florida outbreak, along with EMCVs from Asia, Europe, Africa, and North America. In addition to the prototype outbreak elephant isolate (N-037-19), five other viruses analyzed in subsequent experiments (Figs 7 and 8) are highlighted in the tree: (i) EMCV N-20-413, isolated from a common brown lemur from a zoological facility in south Florida in 2020 (serotype 1), (ii) EMCV N-19-013, derived from an East African hippopotamus at a Texas zoo in 2018 (serotype 1), (iii) EMCV ZM12/14, isolated from a multimammate mouse in Zambia in 2012 (serotype 1), (iv) EMCV RD-1338, recovered from a wood mouse in Germany in 2005 (serotype 2), and (v) EMCV Sing-M100-02, isolated from an orangutan in Singapore in 2002 (tentatively designated as serotype 3). Nonsynonymous amino acid changes in the five viruses relative to N-037-19 were mapped onto the Mengo virus capsid crystal structure (pdb_00002mev) using PyMOL and are highlighted in red. The tree is mid-point rooted for clarity only. Horizontal branch lengths are scaled according to the number of amino acid substitutions per site. Only SH-like branch supports >0.9 are shown. Viruses are labeled as: host scientific name/ virus ID/ GenBank accession number/ state (where applicable)/ country/ detection or isolation date. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/ej9nobp). Additional images were obtained from VectorStock [95].CC BY · PubMed Central
Fig 4 Maximum likelihood phylogenies based on complete polyprotein and 3D gene sequences of EMCV. (A) Polyprotein (amino acid) and (B) 3D (nucleotide) phylogenetic trees are shown. Three EMCV outbreaks involving elephants, in which sequences are available, are noted: two from zoological settings – Florida, USA in 2019 (this paper) and France in 2013 [28,43] – along with South Africa in 1994, in which 64 free-ranging elephants are thought to have died from EMCV infection [31,44]. Note the association of black rats (Rattus rattus) with both zoological outbreaks on separate continents. The six viruses noted in the capsid phylogeny (Fig 3) are also highlighted in both trees here. Although the topological position of the elephant/black rat French clade differs between the two trees, the associated SH-like branch support values are low. The trees are mid-point rooted for clarity only. The horizontal branch lengths are scaled according to the number of amino acid or nucleotide substitutions per site, respectively. Only SH-like branch supports >0.9 are shown. Viruses are labeled as: host scientific name/ virus ID/ GenBank accession number/ state (where applicable)/ country/ detection or isolation date. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/ukh6rbu).
Fig 4 Maximum likelihood phylogenies based on complete polyprotein and 3D gene sequences of EMCV. (A) Polyprotein (amino acid) and (B) 3D (nucleotide) phylogenetic trees are shown. Three EMCV outbreaks involving elephants, in which sequences are available, are noted: two from zoological settings – Florida, USA in 2019 (this paper) and France in 2013 [28,43] – along with South Africa in 1994, in which 64 free-ranging elephants are thought to have died from EMCV infection [31,44]. Note the association of black rats (Rattus rattus) with both zoological outbreaks on separate continents. The six viruses noted in the capsid phylogeny (Fig 3) are also highlighted in both trees here. Although the topological position of the elephant/black rat French clade differs between the two trees, the associated SH-like branch support values are low. The trees are mid-point rooted for clarity only. The horizontal branch lengths are scaled according to the number of amino acid or nucleotide substitutions per site, respectively. Only SH-like branch supports >0.9 are shown. Viruses are labeled as: host scientific name/ virus ID/ GenBank accession number/ state (where applicable)/ country/ detection or isolation date. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/ukh6rbu).CC BY · PubMed Central
Fig 5 Replicative fitness of EMCV elephant isolate N-037-19 in intestinal and kidney cells of various hosts. (A-E) Multi-step growth curves and EMCV cytopathology in intestinal cells. Cells were infected at an MOI = 0.001 and harvested daily for 7 days. Cells shown are (A) HIEC-6 (human small intestinal enterocytes), (B) CMT-93 (House mouse large intestinal/rectal carcinoma cells), and (C) IEC-18 (Norway rat small intestinal [ileum] epithelial cells). Note EMCV infection in rat intestinal cells is non-cytolytic, in contrast to human and mouse cells. Scale bar = 100µm; (D) An overlay between the three cell lines highlights the reduced replication kinetics observed in rat intestinal cells over time; (E) Growth curves in IEC-18 cells infected with an MOI = 0.001 or 0.1 of EMCV over a 30-day period. Similar to the 7-day growth curve, EMCV infection in IEC-18 cells shows no cytopathology over the course of 30 days and infection is ultimately cleared from cells; (F) Multi-step growth curves in kidney cells from various hosts. Cell lines shown are BHK (Syrian golden hamster), OK (Virginia opossum), Vero E6 (African green monkey), MDCK (domestic dog), and Efk3B (big brown bat). Both BHK and Vero E6 cells, which are defective in interferon production [54,55], are routinely used in viral diagnostics for EMCV. Note a host restriction for EMCV in dog kidney and big brown bat kidney cells. An overlay of growth curves is shown to highlight the differences of titers in various kidney cell lines. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/umgiypr).
Fig 5 Replicative fitness of EMCV elephant isolate N-037-19 in intestinal and kidney cells of various hosts. (A-E) Multi-step growth curves and EMCV cytopathology in intestinal cells. Cells were infected at an MOI = 0.001 and harvested daily for 7 days. Cells shown are (A) HIEC-6 (human small intestinal enterocytes), (B) CMT-93 (House mouse large intestinal/rectal carcinoma cells), and (C) IEC-18 (Norway rat small intestinal [ileum] epithelial cells). Note EMCV infection in rat intestinal cells is non-cytolytic, in contrast to human and mouse cells. Scale bar = 100µm; (D) An overlay between the three cell lines highlights the reduced replication kinetics observed in rat intestinal cells over time; (E) Growth curves in IEC-18 cells infected with an MOI = 0.001 or 0.1 of EMCV over a 30-day period. Similar to the 7-day growth curve, EMCV infection in IEC-18 cells shows no cytopathology over the course of 30 days and infection is ultimately cleared from cells; (F) Multi-step growth curves in kidney cells from various hosts. Cell lines shown are BHK (Syrian golden hamster), OK (Virginia opossum), Vero E6 (African green monkey), MDCK (domestic dog), and Efk3B (big brown bat). Both BHK and Vero E6 cells, which are defective in interferon production [54,55], are routinely used in viral diagnostics for EMCV. Note a host restriction for EMCV in dog kidney and big brown bat kidney cells. An overlay of growth curves is shown to highlight the differences of titers in various kidney cell lines. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/umgiypr).CC BY · PubMed Central
Fig 6 Neutralizing antibody responses to EMCV in autogenous vaccinated African elephants over a 2.5-year period. (A) List of elephants and their demographic data, along with vaccination schedules. Note all elephants received their final vaccine in a series in October 2020. Booster dates for elephants whose titers dropped to 1:20 (AE-02 and AE-06) post-October 2020 are indicated and are also highlighted as green bars in panel C. Note the two remaining oldest elephants – AE-08 and AE-09 – had pre-existing neutralizing antibodies against EMCV prior to vaccination. The deceased elephant (AE-10) did not have any evidence of previous infection. Post-vaccination mean titers indicate the average neutralizing antibody titer per number of sampling times, with corresponding titer ranges over the 30-month period; (B) Linear regression of mean log plaque-reduction neutralization test (PRNT90) titers versus months post-vaccination in elephants (slope = -0.014 [95% CI: -0.018 to -0.010], R2 = 0.62, P< 0.0001). Only elephants that did not receive a booster post-vaccination were included in the analysis; (C) Neutralizing antibody titers in the remaining nine elephants over the course of 30 months post-vaccination. Elephants are listed in order of ascending age. On average, elephants were bled at monthly intervals (mean = 31-35 days), although in some circumstances this may have been extended longer due to unforeseen circumstances as represented along the x-axis. Reciprocal antibody titers were determined using a 90% neutralization cut-off in the PRNT with the autogenous vaccine strain (N-037-19) derived from elephant AE-10 as the challenge virus. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/51w9v48).
Fig 6 Neutralizing antibody responses to EMCV in autogenous vaccinated African elephants over a 2.5-year period. (A) List of elephants and their demographic data, along with vaccination schedules. Note all elephants received their final vaccine in a series in October 2020. Booster dates for elephants whose titers dropped to 1:20 (AE-02 and AE-06) post-October 2020 are indicated and are also highlighted as green bars in panel C. Note the two remaining oldest elephants – AE-08 and AE-09 – had pre-existing neutralizing antibodies against EMCV prior to vaccination. The deceased elephant (AE-10) did not have any evidence of previous infection. Post-vaccination mean titers indicate the average neutralizing antibody titer per number of sampling times, with corresponding titer ranges over the 30-month period; (B) Linear regression of mean log plaque-reduction neutralization test (PRNT90) titers versus months post-vaccination in elephants (slope = -0.014 [95% CI: -0.018 to -0.010], R2 = 0.62, P< 0.0001). Only elephants that did not receive a booster post-vaccination were included in the analysis; (C) Neutralizing antibody titers in the remaining nine elephants over the course of 30 months post-vaccination. Elephants are listed in order of ascending age. On average, elephants were bled at monthly intervals (mean = 31-35 days), although in some circumstances this may have been extended longer due to unforeseen circumstances as represented along the x-axis. Reciprocal antibody titers were determined using a 90% neutralization cut-off in the PRNT with the autogenous vaccine strain (N-037-19) derived from elephant AE-10 as the challenge virus. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/51w9v48).CC BY · PubMed Central
Fig 7 Development of a reverse genetics system for EMCV elephant isolate N-037-19 to evaluate cross-neutralization provided against divergent capsids after autogenous vaccination. (A) Strategy for generating infectious clones with heterologous capsids. The genome for EMCV N-037-19 is shown, which contains 5’ and 3’ UTRs flanking the polyprotein. The polyprotein is subdivided in three regions denoted as P1, P2, and P3, in addition to a leader (L) sequence preceding P1. P1 encodes the capsid proteins, specifically VP1, VP2, VP3, and VP4. Note that the outer capsid surface is composed of VP1-3 (with each protein color-coded for identity), while VP4 is found inside the capsid (shown in orange) and is therefore not exposed on the surface. The P2 and P3 regions encode proteins needed for replication and polyprotein processing and are thus not part of the virion structure; (B) Heterologous capsids generated using the elephant EMCV infectious clone. Three capsids representing EMCV-1 (ZM12/14; GenBank: LC585221), EMCV-2 (RD-1338; GenBank: JX257003), and putative EMCV-3 (Sing-M100-02; GenBank: KC310737) were generated, each with varying numbers of capsid substitutions relative to EMCV N-037-19 as shown. Non-synonymous amino acid changes are highlighted in red and mapped onto the Mengo capsid crystal structure (pdb_00002mev) using PyMOL; (C) Immunofluorescence assays of the three rescued viruses with heterologous capsids versus the elephant N-037-19 infectious clone and wild-type N-037-19 at 24 h post-infection in Vero E6 cells. Cells were infected at an MOI = 0.001 and fixed and stained with a swine anti-EMCV-1 polyclonal antibody and a goat anti-swine IgG Alexa Fluor 488 conjugated secondary antibody. Corresponding images of DAPI-stained nuclei are shown as an inset within each panel to visualize the confluent monolayer. Scale bar = 500µm; (D) Multi-step growth curves of the five viruses over seven days in Vero E6 cells. Note that while RD-1338 (EMCV-2) and ZM12/14 (EMCV-1) had reduced fitness relative to the wild-type and infectious clone N-037-19 viruses, Sing-M100-02 (EMCV-3) exhibited nearly identical growth curves. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/tx8dnpi).
Fig 7 Development of a reverse genetics system for EMCV elephant isolate N-037-19 to evaluate cross-neutralization provided against divergent capsids after autogenous vaccination. (A) Strategy for generating infectious clones with heterologous capsids. The genome for EMCV N-037-19 is shown, which contains 5’ and 3’ UTRs flanking the polyprotein. The polyprotein is subdivided in three regions denoted as P1, P2, and P3, in addition to a leader (L) sequence preceding P1. P1 encodes the capsid proteins, specifically VP1, VP2, VP3, and VP4. Note that the outer capsid surface is composed of VP1-3 (with each protein color-coded for identity), while VP4 is found inside the capsid (shown in orange) and is therefore not exposed on the surface. The P2 and P3 regions encode proteins needed for replication and polyprotein processing and are thus not part of the virion structure; (B) Heterologous capsids generated using the elephant EMCV infectious clone. Three capsids representing EMCV-1 (ZM12/14; GenBank: LC585221), EMCV-2 (RD-1338; GenBank: JX257003), and putative EMCV-3 (Sing-M100-02; GenBank: KC310737) were generated, each with varying numbers of capsid substitutions relative to EMCV N-037-19 as shown. Non-synonymous amino acid changes are highlighted in red and mapped onto the Mengo capsid crystal structure (pdb_00002mev) using PyMOL; (C) Immunofluorescence assays of the three rescued viruses with heterologous capsids versus the elephant N-037-19 infectious clone and wild-type N-037-19 at 24 h post-infection in Vero E6 cells. Cells were infected at an MOI = 0.001 and fixed and stained with a swine anti-EMCV-1 polyclonal antibody and a goat anti-swine IgG Alexa Fluor 488 conjugated secondary antibody. Corresponding images of DAPI-stained nuclei are shown as an inset within each panel to visualize the confluent monolayer. Scale bar = 500µm; (D) Multi-step growth curves of the five viruses over seven days in Vero E6 cells. Note that while RD-1338 (EMCV-2) and ZM12/14 (EMCV-1) had reduced fitness relative to the wild-type and infectious clone N-037-19 viruses, Sing-M100-02 (EMCV-3) exhibited nearly identical growth curves. Image was created, in part, using BioRender (Allison, A. [2026] https://BioRender.com/tx8dnpi).CC BY · PubMed Central
Fig 8 Neutralizing antibody titers of vaccinated elephants against wild-type viruses and infectious clones containing heterologous capsids. (A) Neutralizing antibody titers of vaccinated elephant antisera against (i) the homologous virus used as a vaccine (N-037-19) and its infectious clone, (ii) two recent isolates recovered from fatal zoological cases in Texas (hippopotamus) and south Florida (lemur), and (iii) the N-037-19 infectious clone containing capsids from divergent EMCV-1 (ZM12/14), EMCV-2 (RD-1338), and putative EMCV-3 (Sing-M100-02) isolates. Note that the viruses are ordered in terms of the increasing number of amino acid substitutions in their capsids relative to N-037-19, which were mapped onto the crystal structure of Mengo virus (pdb_00002mev) in PyMOL and shown in red; (B) Alignment of the known antigenic sites previously identified in EMCV [66,67] between the six viruses from panel A. Antigenic sites, based on neutralization escape mutations, include the VP2 surface puff (magenta), VP3 surface knob (orange), and 3 VP1 loop regions (BC loop [red], Loop I [lemon], and Loop 2 [brown]) [68]. Neutralization escape mutations are shown with a green diamond in the alignment. Differences between the viruses outside these sites are colored in gray; (C) Location of antigenic/neutralization escape mutation sites on the capsid. Antigenic sites are color-coded as in panel B. The cartoon of the capsid is shown on the left to highlight the elaborate loop structures that form the major antigenic sites. Escape mutations shown in the alignment are also highlighted in bright green in stick configuration and numbered in the surface map (bottom right). The five-fold pore – where viral RNA is extruded from the capsid – is highlighted in the capsid images with an arrow or yellow pentamer for orientation. The VP1, VP2, and VP3 proteins are highlighted in aqua, gray, and marine blue in the full capsid (upper right) and surface rendition (bottom right) only.
Fig 8 Neutralizing antibody titers of vaccinated elephants against wild-type viruses and infectious clones containing heterologous capsids. (A) Neutralizing antibody titers of vaccinated elephant antisera against (i) the homologous virus used as a vaccine (N-037-19) and its infectious clone, (ii) two recent isolates recovered from fatal zoological cases in Texas (hippopotamus) and south Florida (lemur), and (iii) the N-037-19 infectious clone containing capsids from divergent EMCV-1 (ZM12/14), EMCV-2 (RD-1338), and putative EMCV-3 (Sing-M100-02) isolates. Note that the viruses are ordered in terms of the increasing number of amino acid substitutions in their capsids relative to N-037-19, which were mapped onto the crystal structure of Mengo virus (pdb_00002mev) in PyMOL and shown in red; (B) Alignment of the known antigenic sites previously identified in EMCV [66,67] between the six viruses from panel A. Antigenic sites, based on neutralization escape mutations, include the VP2 surface puff (magenta), VP3 surface knob (orange), and 3 VP1 loop regions (BC loop [red], Loop I [lemon], and Loop 2 [brown]) [68]. Neutralization escape mutations are shown with a green diamond in the alignment. Differences between the viruses outside these sites are colored in gray; (C) Location of antigenic/neutralization escape mutation sites on the capsid. Antigenic sites are color-coded as in panel B. The cartoon of the capsid is shown on the left to highlight the elaborate loop structures that form the major antigenic sites. Escape mutations shown in the alignment are also highlighted in bright green in stick configuration and numbered in the surface map (bottom right). The five-fold pore – where viral RNA is extruded from the capsid – is highlighted in the capsid images with an arrow or yellow pentamer for orientation. The VP1, VP2, and VP3 proteins are highlighted in aqua, gray, and marine blue in the full capsid (upper right) and surface rendition (bottom right) only.CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 1 Not valid · 25 Not checked · 127 Own results and interpretations

79 more claims

Create a free account to see all 159 claims and to verify the 49 references still open.

See all claims — free account
  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 65

Create a free account to see these claims.

Citations

Cites

Show all 79 references

Research works printed but not linked: 8

  1. VR. Racaniello, 2013, Picornaviridae: The viruses and their replication., 453
  2. GWA Dick, 1948, Mengo encephalomyelitis virus: isolation and immunological properties, Br J Exp Pathol, 29, 547
  3. SK Wells, 1989, Encephalomyocarditis Virus: Epizootic in a Zoological Collection, J Zoo Wildl Med, 20, 291
  4. JM Gaskin, 1980, The tragedy of encephalomyocarditis virus infection in zoological parks of Florida, Proc Am Assoc Zoo Vet, 1980, 1
  5. AMQ King, 2012, Family adenoviridae, 125
  6. JH Gainer, 1961, Studies on the natural and experimental infections of animals in Florida with the encephalomyocarditis virus, Proc Annu Meet US Livest Sanit Assoc, 65, 556
  7. JM. Gaskin, 2016, Encephalomyocarditis Virus Infection., 718
  8. T Dermody, 2013, Orthoreoviruses., 1304

Cited by

See all 1

Metadata

Authors
Adhikari, A., Feng, K. H., Shrestha, A., Rodriguez, C. E., Nolan, E. C., Pye, G. W., Gauger, P. C., Denagamage, T., Holmes, E. C., & Allison, A. B.
Affiliations
  • University of Florida (US)
  • Iowa State University (US)
  • The University of Sydney (AU)
Corresponding author
Allison, Andrew B.
Venue
PLOS Pathogens
Published
2026-02-17
Volume
22
Issue
2
Pages
e1013861
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W7129372720
Cited by
1
References
79
Citations by year
2026: 1
FWCI
3.84
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Morris Animal Foundation (D20ZO-020)
  • University of Florida College of Veterinary Medicine
Topics
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords
encephalomyocarditis virus, elephants, picornavirus, rodent reservoirs, invasive rodents, phylogenomics, antigenic variation, autogenous vaccine, neutralizing antibodies, cross-protection, reverse genetics, vaccine-induced protection, viral evolution
MeSH terms
Animals, Animals, Zoo, Disease Outbreaks, Encephalomyocarditis virus, Phylogeny, United States, Cardiovirus Infections, Capsid Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Zoological transmission of encephalomyocarditis virus in the United States: Virus evolution, host ecology, and capsid antigenicity derived from an outbreak. https://app.cochat.ai/papers/10.1371/journal.ppat.1013861
The paper
Adhikari, A., Feng, K. H., Shrestha, A., Rodriguez, C. E., Nolan, E. C., Pye, G. W., Gauger, P. C., Denagamage, T., Holmes, E. C., & Allison, A. B. (2026). Zoological transmission of encephalomyocarditis virus in the United States: Virus evolution, host ecology, and capsid antigenicity derived from an outbreak. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013861

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.